Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Program and patient characteristics for the United States Expanded Access Program to COVID-19 convalescent plasma

View ORCID ProfileJonathon W. Senefeld, View ORCID ProfilePatrick W. Johnson, View ORCID ProfileKatie L. Kunze, View ORCID ProfileNoud van Helmond, View ORCID ProfileStephen A. Klassen, View ORCID ProfileChad C. Wiggins, View ORCID ProfileKatelyn A. Bruno, View ORCID ProfileMichael A. Golafshar, View ORCID ProfileMolly M. Petersen, View ORCID ProfileMatthew R. Buras, View ORCID ProfileAllan M. Klompas, View ORCID ProfileMatthew A. Sexton, View ORCID ProfileJuan C. Diaz Soto, View ORCID ProfileSarah E. Baker, View ORCID ProfileJohn R.A. Shepherd, Nicole C. Verdun, View ORCID ProfilePeter Marks, Camille M. van Buskirk, View ORCID ProfileJeffrey L. Winters, View ORCID ProfileJames R. Stubbs, Robert F. Rea, View ORCID ProfileVitaly Herasevich, View ORCID ProfileEmily R. Whelan, View ORCID ProfileAndrew J. Clayburn, View ORCID ProfileKathryn F. Larson, View ORCID ProfileJuan G. Ripoll, View ORCID ProfileKylie J. Andersen, View ORCID ProfileMatthew N.P. Vogt, View ORCID ProfileJoshua J. Dennis, View ORCID ProfileRiley J. Regimbal, View ORCID ProfilePhilippe R. Bauer, View ORCID ProfileJanis E. Blair, Katherine Wright, Joel T. Greenshields, View ORCID ProfileNigel S. Paneth, View ORCID ProfileDeLisa Fairweather, View ORCID ProfileR. Scott Wright, View ORCID ProfileArturo Casadevall, View ORCID ProfileRickey E. Carter, View ORCID ProfileMichael J. Joyner
doi: https://doi.org/10.1101/2021.04.08.21255115
Jonathon W. Senefeld
1Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, United States of America
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jonathon W. Senefeld
  • For correspondence: senefeld.jonathon@mayo.edu
Patrick W. Johnson
2Department of Health Sciences Research, Mayo Clinic, Jacksonville, Florida, United States of America
B.S.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Patrick W. Johnson
Katie L. Kunze
3Department of Health Sciences Research, Mayo Clinic, Scottsdale, Arizona, United States of America
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Katie L. Kunze
Noud van Helmond
4Department of Anesthesiology, Cooper Medical School of Rowan University, Cooper University Health Care, Camden, New Jersey, United States of America
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Noud van Helmond
Stephen A. Klassen
1Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, United States of America
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Stephen A. Klassen
Chad C. Wiggins
1Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, United States of America
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Chad C. Wiggins
Katelyn A. Bruno
5Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, Florida, United States of America
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Katelyn A. Bruno
Michael A. Golafshar
3Department of Health Sciences Research, Mayo Clinic, Scottsdale, Arizona, United States of America
M.S.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael A. Golafshar
Molly M. Petersen
3Department of Health Sciences Research, Mayo Clinic, Scottsdale, Arizona, United States of America
B.S.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Molly M. Petersen
Matthew R. Buras
3Department of Health Sciences Research, Mayo Clinic, Scottsdale, Arizona, United States of America
M.S.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Matthew R. Buras
Allan M. Klompas
1Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, United States of America
M.B., B.Ch., B.A.O.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Allan M. Klompas
Matthew A. Sexton
1Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, United States of America
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Matthew A. Sexton
Juan C. Diaz Soto
1Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, United States of America
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Juan C. Diaz Soto
Sarah E. Baker
1Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, United States of America
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sarah E. Baker
John R.A. Shepherd
1Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, United States of America
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for John R.A. Shepherd
Nicole C. Verdun
6Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, United States of America
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Marks
6Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, United States of America
M.D., Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Peter Marks
Camille M. van Buskirk
7Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey L. Winters
7Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jeffrey L. Winters
James R. Stubbs
7Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for James R. Stubbs
Robert F. Rea
8Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, United States of America
M.D
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vitaly Herasevich
1Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, United States of America
M.D., Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Vitaly Herasevich
Emily R. Whelan
5Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, Florida, United States of America
B.S.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Emily R. Whelan
Andrew J. Clayburn
1Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, United States of America
B.S.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrew J. Clayburn
Kathryn F. Larson
8Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, United States of America
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kathryn F. Larson
Juan G. Ripoll
1Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, United States of America
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Juan G. Ripoll
Kylie J. Andersen
1Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, United States of America
B.S.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kylie J. Andersen
Matthew N.P. Vogt
1Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, United States of America
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Matthew N.P. Vogt
Joshua J. Dennis
1Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, United States of America
B.S.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joshua J. Dennis
Riley J. Regimbal
1Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, United States of America
B.S.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Riley J. Regimbal
Philippe R. Bauer
9Department of Internal Medicine, Division of Pulmonary and Critical Care, Mayo Clinic, Rochester, Minnesota, United States of America
M.D., Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Philippe R. Bauer
Janis E. Blair
10Department of Internal Medicine, Division of Infectious Diseases, Mayo Clinic, Phoenix, Arizona, United States of America
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Janis E. Blair
Katherine Wright
11School of Sustainability, Arizona State University, Tempe, Arizona, United States of America
BA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joel T. Greenshields
12Department of Kinesiology, Indiana University, Bloomington, Indiana, United States of America
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nigel S. Paneth
13Departments of Epidemiology and Biostatistics and Pediatrics and Human Development, College of Human Medicine, Michigan State University, East Lansing, Michigan, United States of America
M.D., M.P.H.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nigel S. Paneth
DeLisa Fairweather
5Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, Florida, United States of America
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for DeLisa Fairweather
R. Scott Wright
8Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, United States of America
14Department of Human Research Protection Program, Mayo Clinic, Rochester, Minnesota, United States of America
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for R. Scott Wright
Arturo Casadevall
15Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America
M.D., Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Arturo Casadevall
Rickey E. Carter
2Department of Health Sciences Research, Mayo Clinic, Jacksonville, Florida, United States of America
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rickey E. Carter
Michael J. Joyner
1Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, United States of America
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael J. Joyner
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The United States (US) Expanded Access Program (EAP) to COVID-19 convalescent plasma was initiated in response to the rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease-2019 (COVID-19). While randomized clinical trials were in various stages of development and enrollment, there was an urgent need for widespread access to potential therapeutic agents particularly for vulnerable racial and ethnic minority populations who were disproportionately affected by the pandemic. The objective of this study is to report on the demographic, geographic, and chronological access to COVID-19 convalescent plasma in the US via the EAP.

Methods and findings Mayo Clinic served as the central IRB for all participating facilities and any US physician could participate as local physician–principal investigator. Registration occurred through the EAP central website. Blood banks rapidly developed logistics to provide convalescent plasma to hospitalized patients with COVID-19. Demographic and clinical characteristics of all enrolled patients in the EAP were summarized. Temporal trends in access to COVID-19 convalescent plasma were investigated by comparing daily and weekly changes in EAP enrollment in response to changes in infection rate on a state level. Geographical analyses on access to convalescent plasma included assessing EAP enrollment in all national hospital referral regions as well as assessing enrollment in metropolitan and less populated areas which did not have access to COVID-19 clinical trials.

From April 3 to August 23, 2020, 105,717 hospitalized patients with severe or life-threatening COVID-19 were enrolled in the EAP. A majority of patients were older than 60 years of age (57.8%), male (58.4%), and overweight or obese (83.8%). There was substantial inclusion of minorities and underserved populations, including 46.4% of patients with a race other than White, and 37.2% of patients were of Hispanic ethnicity. Severe or life-threatening COVID-19 was present in 61.8% of patients and 18.9% of patients were mechanically ventilated at time of convalescent plasma infusion. Chronologically and geographically, increases in enrollment in the EAP closely followed confirmed infections across all 50 states. Nearly all national hospital referral regions enrolled patients in the EAP, including both in metropolitan and less populated areas.

Conclusions The EAP successfully provided widespread access to COVID-19 convalescent plasma in all 50 states, including for underserved racial and ethnic minority populations. The efficient study design of the EAP may serve as an example framework for future efforts when broad access to a treatment is needed in response to a dynamic disease affecting demographic groups and areas historically underrepresented in clinical studies.

Competing Interest Statement

United Health Group, Millennium Pharmaceuticals, and Octapharma USA Inc., supported this project. No other disclosures were reported.

Clinical Trial

NCT04338360

Funding Statement

This project has been funded in part with Federal funds from the Department of Health and Human Services; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority under Contract No. 75A50120C00096. Additionally, this study was supported in part by National Center for Advancing Translational Sciences (NCATS) grant UL1TR002377, National Heart, Lung, and Blood Institute (NHLBI) grant 5R35HL139854 (to MJJ) and grant 1F32HL154320 (to JWS), Natural Sciences and Engineering Research Council of Canada (NSERC) PDF-532926-2019 (to SAK), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 5T32DK07352 (to CCW), National Institute of Allergy and Infectious Disease (NIAID) grants R21 AI145356, R21 AI152318 and R21 AI154927 (to DF), R01 AI152078 9 (to AC), National Heart Lung and Blood Institute RO1 HL059842 (to AC), National Institute on Aging (NIA) U54AG044170 (to SEB), Schwab Charitable Fund (Eric E Schmidt, Wendy Schmidt donors), United Health Group, National Basketball Association (NBA), Millennium Pharmaceuticals, Octapharma USA, Inc, and the Mayo Clinic.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Mayo Clinic Institutional Review Board (IRB), the central IRB for the registry, approved the protocol (IRB #20-0033412, NCT#: NCT04338360), all amendments, and provided regulatory oversight for all sites and investigators. The principal investigator (M.J.J.) was the regulatory sponsor. A Data and Safety Monitoring Board oversaw the safety analyses and advised the regulatory sponsor and the Mayo Clinic IRB on risk.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Individual participant data underlying the results reported in this publication, along with a data dictionary, will be made available to approved investigators for secondary analyses following the completion of the objectives of the United States Expanded Access Program to COVID-19 convalescent plasma. Limited and de-identified data sets will be deposited into a research data repository and may be shared with investigators under controlled access procedures as approved by the Mayo Clinic Institutional Review Board. A scientific committee will review requests for the conduct of protocols approved or determined to be exempt by an Institutional Review Board. Requestors will be required to sign a data use agreement. Data sharing must be compliant with all applicable Mayo Clinic policies.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted April 11, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Program and patient characteristics for the United States Expanded Access Program to COVID-19 convalescent plasma
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Program and patient characteristics for the United States Expanded Access Program to COVID-19 convalescent plasma
Jonathon W. Senefeld, Patrick W. Johnson, Katie L. Kunze, Noud van Helmond, Stephen A. Klassen, Chad C. Wiggins, Katelyn A. Bruno, Michael A. Golafshar, Molly M. Petersen, Matthew R. Buras, Allan M. Klompas, Matthew A. Sexton, Juan C. Diaz Soto, Sarah E. Baker, John R.A. Shepherd, Nicole C. Verdun, Peter Marks, Camille M. van Buskirk, Jeffrey L. Winters, James R. Stubbs, Robert F. Rea, Vitaly Herasevich, Emily R. Whelan, Andrew J. Clayburn, Kathryn F. Larson, Juan G. Ripoll, Kylie J. Andersen, Matthew N.P. Vogt, Joshua J. Dennis, Riley J. Regimbal, Philippe R. Bauer, Janis E. Blair, Katherine Wright, Joel T. Greenshields, Nigel S. Paneth, DeLisa Fairweather, R. Scott Wright, Arturo Casadevall, Rickey E. Carter, Michael J. Joyner
medRxiv 2021.04.08.21255115; doi: https://doi.org/10.1101/2021.04.08.21255115
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Program and patient characteristics for the United States Expanded Access Program to COVID-19 convalescent plasma
Jonathon W. Senefeld, Patrick W. Johnson, Katie L. Kunze, Noud van Helmond, Stephen A. Klassen, Chad C. Wiggins, Katelyn A. Bruno, Michael A. Golafshar, Molly M. Petersen, Matthew R. Buras, Allan M. Klompas, Matthew A. Sexton, Juan C. Diaz Soto, Sarah E. Baker, John R.A. Shepherd, Nicole C. Verdun, Peter Marks, Camille M. van Buskirk, Jeffrey L. Winters, James R. Stubbs, Robert F. Rea, Vitaly Herasevich, Emily R. Whelan, Andrew J. Clayburn, Kathryn F. Larson, Juan G. Ripoll, Kylie J. Andersen, Matthew N.P. Vogt, Joshua J. Dennis, Riley J. Regimbal, Philippe R. Bauer, Janis E. Blair, Katherine Wright, Joel T. Greenshields, Nigel S. Paneth, DeLisa Fairweather, R. Scott Wright, Arturo Casadevall, Rickey E. Carter, Michael J. Joyner
medRxiv 2021.04.08.21255115; doi: https://doi.org/10.1101/2021.04.08.21255115

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (551)
  • Anesthesia (135)
  • Cardiovascular Medicine (1751)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (312)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (656)
  • Epidemiology (10790)
  • Forensic Medicine (8)
  • Gastroenterology (585)
  • Genetic and Genomic Medicine (2939)
  • Geriatric Medicine (287)
  • Health Economics (532)
  • Health Informatics (1921)
  • Health Policy (833)
  • Health Systems and Quality Improvement (744)
  • Hematology (291)
  • HIV/AIDS (628)
  • Infectious Diseases (except HIV/AIDS) (12508)
  • Intensive Care and Critical Care Medicine (687)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (324)
  • Neurology (2789)
  • Nursing (151)
  • Nutrition (432)
  • Obstetrics and Gynecology (556)
  • Occupational and Environmental Health (597)
  • Oncology (1460)
  • Ophthalmology (443)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (380)
  • Pediatrics (865)
  • Pharmacology and Therapeutics (363)
  • Primary Care Research (336)
  • Psychiatry and Clinical Psychology (2635)
  • Public and Global Health (5349)
  • Radiology and Imaging (1007)
  • Rehabilitation Medicine and Physical Therapy (595)
  • Respiratory Medicine (725)
  • Rheumatology (329)
  • Sexual and Reproductive Health (289)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (125)